Table 2.
Pathology and procedure
| Surgical procedure (n = 198) | No | (%) |
| Open radical nephrectomy | 57 | (28.7) |
| Laparoscopic radical nephrectomy | 42 | (21.2) |
| Robotic assisted radical nephrectomy | 6 | (3.0) |
| Open partial nephrectomy | 26 | (13.1) |
| Laparoscopic partial nephrectomy | 19 | (9.5) |
| Robotic partial nephrectomy | 27 | (13.6) |
| Radical nephrectomy with IVC thrombectomy | 12 | (6) |
| Cytoreductive nephrectomy | 9 | (4.5) |
| Final histopathology (n = 198) | ||
| Benign (n = 29) | No | (%) |
| Angiomyolipoma | 15 | (7.5) |
| Oncocytoma | 10 | (5.0) |
| Adenoma | 2 | (1.0) |
| Mixed epithelial stromal tumor | 2 | (1.0) |
| Malignant (n = 169) | No | (%) |
| Renal cell carcinoma (RCC) | ||
| Clear cell | 101 | (51.0) |
| Papillary | 24 | (12.1) |
| Variant histology | 18 | (9.0) |
| Chromophobe | 12 | (6.0) |
| Non-RCC | ||
| PNET | 5 | (2.5) |
| Ewing’s sarcoma | 3 | (1.5) |
| Wilm'stumor | 2 | (1.0) |
| Rhabdomyosarcoma | 1 | (0.5) |
| Extra intestinal GIST | 1 | (0.5) |
| Metastasis | 1 | (0.5) |
| Liposarcoma | 1 | (0.5) |
| Pathological Stage* (n = 169) | No | (%) |
| T1a | 47 | (27.8) |
| T1b | 46 | (27.2) |
| T2a | 21 | (12.4) |
| T2b | 18 | (10.6) |
| T3a | 23 | (13.6) |
| T3b | 8 | (4.7) |
| T3c | 4 | (2.3) |
| T4 | 2 | (1.1) |
| Nodes | 3 | (1.7)* |
| Metastasis | 9 | (5.3)* |
*Pathological stage, node positivity and metastasis taken in relation to malignant tumors